NCT07078682
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
At risk: Primary completion moved at least 9 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
Version history last read from ClinicalTrials.gov on Aug 31, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Jan 2026 to Nov 2026
- Enrollment closed, study ongoing
- Notable Trial status: Not Yet Recruiting to Recruiting
- Site details revised
- Study title shortened, about 1 word
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change in uterine fibroid-related symptom severity
Timeframe: Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24
Secondary (1)
Change in fibroid-related health-related quality of life domains
Arms and interventions
Elix Cycle Balance & Elix Daily HarmonyExperimental
Participants will receive two investigational herbal supplements daily for 24 weeks.
Dietary supplements: Elix Daily Harmony
Sites
1 site in 1 country
- CitruslabsLas Vegas, Nevada, United States